Kestra Medical Technologies annual return on equity
2026
Kestra Medical Technologies Return on Equity (ROE) Growth & History (KMTS)
Kestra Medical Technologies's return on equity was −56.60% for fiscal 2026.
View full Kestra Medical Technologies company overviewKestra Medical Technologies annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-04-30 | −56.60% | — |
Kestra Medical Technologies quarterly return on equity
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2026 | 2026-04-30 | −14.18% | — |
| Q3 2026 | 2026-01-31 | −15.12% | — |
| Q2 2026 | 2025-10-31 | −18.83% | — |
| Q1 2026 | 2025-07-31 | −13.26% | — |
Kestra Medical Technologies return on equity trends
The latest reported quarter, Q4 2026, shows −14.18%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kestra Medical Technologies source filings ↗